1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  05/16 05:46:46 am EDT
23.42 EUR   -0.02%
05:01aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05:00aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
04:01aNew release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips : Periodic update on transaction details related to Philips' share repurchases

01/14/2022 | 05:12am EDT
Jan 14, 2022
Periodic update on transaction details related to Philips' share repurchases
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from January 7, 2022 up to and including January 12, 2022 a total of 528,639 of its own common shares were repurchased, with a weighted average purchase price of EUR 30.37. These repurchases conclude the open market share repurchases under the repurchase program for capital reduction purposes that was announced on July 26, 2021. Since the start of the program, Philips also entered into a number of forward transactions, with settlement dates in 2022, 2023 and 2024. Further details can be found via this link.
About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Disclaimer

Royal Philips NV published this content on 14 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 January 2022 10:11:00 UTC.


ę Publicnow 2022
All news about PHILIPS NV
05:01aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05:00aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
04:01aNew release of Philips EchoNavigator helps interventional teams treat structural heart ..
GL
05/12PHILIPS NV : Ex-dividend day for final dividend (optional)
FA
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
05/10Philips Annual General Meeting of Shareholders approves dividend and other proposals ma..
GL
05/10Royal Philips Approves Appointment of Mrs. Herna Verhagen and Mr. Sanjay Poonen as Memb..
CI
05/10Royal Philips Approves Dividend for the Year 2021
CI
05/10TRANSCRIPT : Koninklijke Philips N.V. - Shareholder/Analyst Call
CI
05/09SECTOR UPDATE : Health Care Stocks Decline Premarket Monday
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 18 269 M 19 016 M 19 016 M
Net income 2022 795 M 827 M 827 M
Net Debt 2022 4 113 M 4 281 M 4 281 M
P/E ratio 2022 23,7x
Yield 2022 3,72%
Capitalization 20 359 M 21 192 M 21 192 M
EV / Sales 2022 1,34x
EV / Sales 2023 1,25x
Nbr of Employees 78 189
Free-Float 97,5%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 23,42 €
Average target price 32,18 €
Spread / Average Target 37,4%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-28.52%21 192
THERMO FISHER SCIENTIFIC-18.86%211 945
DANAHER CORPORATION-24.26%178 394
INTUITIVE SURGICAL, INC.-37.74%80 295
SIEMENS HEALTHINEERS AG-17.38%63 485
EDWARDS LIFESCIENCES CORPORATION-24.70%60 652